Product
Td vaccine
2 clinical trials
4 indications
Indication
Malignant GliomaIndication
High-Grade GliomaIndication
OligodendrogliomaIndication
Progressive OligodendrogliomaClinical trial
ACTION Trial: Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I).Status: Active (not recruiting), Estimated PCD: 2026-05-01
Clinical trial
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01